Your browser doesn't support javascript.
loading
Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia-reperfusion injury.
Weng, Xueyi; Tan, Haipeng; Huang, Zheyong; Chen, Jing; Zhang, Ning; Wang, Qiaozi; Li, Qiyu; Gao, Jinfeng; Sun, Dili; Yakufu, Wusiman; Wang, Zhengmin; Li, Weiyan; Zhu, Guangrui; Pang, Zhiqing; Song, Yanan; Qian, Juying; Ge, Junbo.
Affiliation
  • Weng X; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Tan H; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Huang Z; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Chen J; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Zhang N; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Wang Q; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Li Q; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Gao J; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Sun D; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Yakufu W; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Wang Z; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Li W; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Zhu G; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Pang Z; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Song Y; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
  • Qian J; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine, 180 Feng Lin Road, Shanghai, 200032, China.
  • Ge J; Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases , Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
J Nanobiotechnology ; 20(1): 454, 2022 Oct 20.
Article in En | MEDLINE | ID: mdl-36266658

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Reperfusion Injury / Liposomes Limits: Animals Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Reperfusion Injury / Liposomes Limits: Animals Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article Affiliation country: Country of publication: